Evidence map›Paper›PMID 25899391›Full record

ArticleHead & neck2016

Clinical outcomes in elderly patients with human papillomavirus-positive squamous cell carcinoma of the oropharynx treated with definitive chemoradiation therapy.

Sheela Hanasoge, Kelly R Magliocca, Jeffrey M Switchenko, Nabil F Saba, J Trad Wadsworth, Mark W El-Deiry, Dong M Shin, Fadlo Khuri, Jonathan J Beitler, Kristin A Higgins

Abstract read
In one paragraph

Article in Head & neck, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sheela HanasogeDepartment of Radiation Oncology, Emory University, Atlanta, Georgia.
Kelly R MaglioccaDepartment of Pathology, Emory University, Atlanta, Georgia.
Jeffrey M SwitchenkoDepartment of Biostatistics and Bioinformatics, Emory University, Atlanta, Georgia.
Nabil F SabaDepartment of Hematology and Medical Oncology, Emory University, Atlanta, Georgia.
J Trad WadsworthDepartment of Otolaryngology - Head and Neck Surgery, Emory University, Atlanta, Georgia.
Mark W El-DeiryDepartment of Otolaryngology - Head and Neck Surgery, Emory University, Atlanta, Georgia.
Dong M ShinDepartment of Hematology and Medical Oncology, Emory University, Atlanta, Georgia.
Fadlo KhuriDepartment of Hematology and Medical Oncology, Emory University, Atlanta, Georgia.
Jonathan J BeitlerDepartment of Radiation Oncology, Emory University, Atlanta, Georgia.
Kristin A HigginsDepartment of Radiation Oncology, Emory University, Atlanta, Georgia.

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
NCI NIH HHS P30 CA138292
6 · The paper itself

Abstract

backgroundThe benefit of combined chemoradiation in elderly patients with human papillomavirus (HPV)-positive locally advanced oropharyngeal squamous cell carcinoma (SCC) must be balanced with the potential for higher toxicity rates. We performed a retrospective review of our institutional experience.

methodsPatients 70 years or older with p16-positive oropharyngeal SCC treated with definitive chemoradiation from 2005 to 2013 were evaluated. Overall survival (OS), disease-free survival (DFS), and locoregional failure-free survival were calculated.

resultsTwenty-one eligible patients had a follow-up of 22.4 months. Estimated 5-year OS, DFS, and locoregional failure-free survival were 76.0%, 40%, and 95%, respectively. There was 1 death from acute toxicity, and 50% had unplanned hospitalizations. Sixty percent had late toxicity, and 6-month feeding tube dependence was 25%.

conclusionElderly patients with HPV-positive locally advanced SCC of the oropharynx treated with definitive chemoradiation had good OS but high rates of acute and long-term toxicity. © 2015 Wiley Periodicals, Inc. Head Neck 38: 846-851, 2015.

Indexed as

AgedCarcinoma, Squamous CellChemoradiotherapyFemaleHuman papillomavirus 16HumansMaleOropharyngeal NeoplasmsPapillomavirus InfectionsRetrospective StudiesSurvival AnalysisTreatment Outcomechemoradiationelderlyhuman papillomavirus-positive (HPV+)oropharyngeal cancer

Identifiers

PMID25899391
PMCPMC4959784

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.